Invention Grant
- Patent Title: Expression, purification and uses of a plasmodium falciparum liver stage antigen 1 polypeptide
- Patent Title (中): 恶性疟原虫肝阶段抗原1多肽的表达，纯化和应用
-
Application No.: US12454240Application Date: 2009-05-14
-
Publication No.: US08268615B2Publication Date: 2012-09-18
- Inventor: David E. Lanar , Collette J. Hillier , Jeffrey A. Lyon , Evelina Angov , Sanjai Kumar , William Rogers , Arnoldo Barbosa
- Applicant: David E. Lanar , Collette J. Hillier , Jeffrey A. Lyon , Evelina Angov , Sanjai Kumar , William Rogers , Arnoldo Barbosa
- Applicant Address: US DC Washington
- Assignee: The United States of America as Represented by the Secretary of the Army
- Current Assignee: The United States of America as Represented by the Secretary of the Army
- Current Assignee Address: US DC Washington
- Agent Elizabeth Arwine
- Main IPC: C12N15/00
- IPC: C12N15/00 ; A61K39/002
Abstract:
In this application is described the expression and purification of a recombinant Plasmodium falciparum (3D7) LSA-NRC polypeptide. The method of the present invention produces a highly purified polypeptide which is useful as a vaccine and as a diagnostic reagent.
Public/Granted literature
- US20100040640A1 Expression, purification and uses of a plasmodium falciparum liver stage antigen 1 polypeptide Public/Granted day:2010-02-18
Information query
IPC分类:
